• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

功能性血管紧张素II 2型受体抑制LNCaP和PC3前列腺癌细胞系中的生长因子信号传导。

Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.

作者信息

Chow L, Rezmann L, Imamura K, Wang L, Catt K, Tikellis C, Louis W J, Frauman A G, Louis S N S

机构信息

Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.

出版信息

Prostate. 2008 May 1;68(6):651-60. doi: 10.1002/pros.20738.

DOI:10.1002/pros.20738
PMID:18288685
Abstract

BACKGROUND

There is clear evidence of a tissue-based renin-angiotensin system in the prostate and studies to date suggest that AT(1)-receptor blocking drugs inhibit the growth of some prostate cancer cell lines and delay the development of prostate cancer. The present studies examine the action of Ang II in two prostate cancer cell lines and report the presence of functional AT(2)-receptors that regulate the actions of growth factors.

METHODS

Immunohistochemistry was used to identify the presence of Ang II and QPCR techniques to examine AT(1)- and AT(2)-receptor mRNA expression in androgen-dependent (LNCaP) and independent (PC3) cell lines. The effects of AT(1)- and AT(2)-receptor activation upon EGF-induced DNA synthesis and ERK2 phosphorylation in these cells were also examined.

RESULTS

Functional AT(2)-receptors together with Ang II were identified in both cell lines and stimulation of these receptors inhibited EGF-induced DNA synthesis and ERK2 phosphorylation. AT(1)-receptors, although present in both cell lines, were only functional in LNCaP cells where activation stimulated DNA synthesis.

CONCLUSIONS

Functional AT(2)-receptors are present and have the capacity to inhibit EGF-induced prostate cancer cell growth in LNCaP and fast growing androgen-independent PC3 cell lines, whereas functional AT(1)-receptors are found only in LNCaP cells where their activation stimulates DNA synthesis.

摘要

背景

有明确证据表明前列腺中存在基于组织的肾素-血管紧张素系统,并且迄今为止的研究表明,AT(1)受体阻断药物可抑制某些前列腺癌细胞系的生长并延缓前列腺癌的发展。本研究检测了血管紧张素II(Ang II)在两种前列腺癌细胞系中的作用,并报告了调节生长因子作用的功能性AT(2)受体的存在。

方法

采用免疫组织化学法鉴定Ang II的存在,并用定量聚合酶链反应(QPCR)技术检测雄激素依赖性(LNCaP)和非依赖性(PC3)细胞系中AT(1)和AT(2)受体mRNA的表达。还检测了AT(1)和AT(2)受体激活对这些细胞中表皮生长因子(EGF)诱导的DNA合成和细胞外信号调节激酶2(ERK2)磷酸化的影响。

结果

在两种细胞系中均鉴定出功能性AT(2)受体以及Ang II,刺激这些受体可抑制EGF诱导的DNA合成和ERK2磷酸化。AT(1)受体虽然在两种细胞系中均有表达,但仅在LNCaP细胞中具有功能,其激活可刺激DNA合成。

结论

功能性AT(2)受体存在,并且能够抑制LNCaP和快速生长的雄激素非依赖性PC3细胞系中EGF诱导的前列腺癌细胞生长,而功能性AT(1)受体仅在LNCaP细胞中发现,其激活可刺激DNA合成。

相似文献

1
Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.功能性血管紧张素II 2型受体抑制LNCaP和PC3前列腺癌细胞系中的生长因子信号传导。
Prostate. 2008 May 1;68(6):651-60. doi: 10.1002/pros.20738.
2
Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.肝素结合表皮生长因子(HB-EGF)、双调蛋白、转化生长因子α和表皮调节素在雄激素非依赖性前列腺癌细胞系中的表达增加。
Anticancer Res. 2000 Jan-Feb;20(1A):91-5.
3
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.表皮生长因子(EGF)受体阻断可抑制表皮生长因子、胰岛素样生长因子I以及蛋白激酶A激活剂对前列腺癌细胞系中丝裂原活化蛋白激酶途径的作用。
Cancer Res. 1999 Jan 1;59(1):227-33.
4
Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.前列腺癌中的生长激素(GH)受体:在人体组织和细胞系中的基因表达及特性、LNCaP细胞中的GH信号传导与雄激素受体调控
Mol Cell Endocrinol. 2004 May 31;220(1-2):109-23. doi: 10.1016/j.mce.2004.03.004.
5
Regulation of growth hormone receptors in human prostate cancer cell lines.人前列腺癌细胞系中生长激素受体的调控
Mol Cell Endocrinol. 2009 Oct 15;309(1-2):82-92. doi: 10.1016/j.mce.2009.06.004. Epub 2009 Jun 18.
6
Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.褪黑素与前列腺癌细胞增殖:与去势、表皮生长因子及雄激素敏感性的相互作用
Prostate. 2002 Jul 1;52(2):106-22. doi: 10.1002/pros.10098.
7
Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.类固醇受体通过Src对乳腺癌和前列腺癌细胞中表皮生长因子信号传导的调节:类固醇拮抗剂作用
Cancer Res. 2005 Nov 15;65(22):10585-93. doi: 10.1158/0008-5472.CAN-05-0912.
8
Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.血管紧张素II通过I型血管紧张素II受体上调前列腺癌中PAX2癌基因的表达和活性。
Prostate. 2009 Sep 1;69(12):1334-42. doi: 10.1002/pros.20980.
9
Angiotensin receptors in hormone-independent prostate cancer cell line DU145: presence of two variants of angiotensin type 1 receptor.激素非依赖性前列腺癌细胞系DU145中的血管紧张素受体:血管紧张素1型受体存在两种变体
Med Sci Monit. 2009 Apr;15(4):BR106-10.
10
Renin-angiotensin system is an important factor in hormone refractory prostate cancer.肾素-血管紧张素系统是激素难治性前列腺癌的一个重要因素。
Prostate. 2006 Jun 1;66(8):822-30. doi: 10.1002/pros.20407.

引用本文的文献

1
An Insight into GPCR and G-Proteins as Cancer Drivers.G 蛋白偶联受体(GPCR)和 G 蛋白作为癌症驱动因素的深入了解。
Cells. 2021 Nov 24;10(12):3288. doi: 10.3390/cells10123288.
2
The current status of anti-GPCR drugs against different cancers.抗G蛋白偶联受体(GPCR)药物针对不同癌症的现状。
J Pharm Anal. 2020 Dec;10(6):517-521. doi: 10.1016/j.jpha.2020.01.001. Epub 2020 Jan 11.
3
Glioblastoma Multiforme Cancer Stem Cells Express Components of the Renin-Angiotensin System.多形性胶质母细胞瘤癌症干细胞表达肾素-血管紧张素系统的成分。
Front Surg. 2016 Sep 27;3:51. doi: 10.3389/fsurg.2016.00051. eCollection 2016.
4
Experimental and DFT characterization, antioxidant and anticancer activities of a Cu(II)-irbesartan complex: structure-antihypertensive activity relationships in Cu(II)-sartan complexes.一种铜(II)-厄贝沙坦配合物的实验与密度泛函理论表征、抗氧化及抗癌活性:铜(II)-沙坦类配合物的结构-降压活性关系
J Biol Inorg Chem. 2016 Oct;21(7):851-63. doi: 10.1007/s00775-016-1384-5. Epub 2016 Aug 9.
5
Adenovirus-Mediated Angiotensin II Type 2 Receptor Overexpression Inhibits Tumor Growth of Prostate Cancer In Vivo.腺病毒介导的血管紧张素II 2型受体过表达抑制前列腺癌体内肿瘤生长。
J Cancer. 2016 Jan 1;7(2):184-91. doi: 10.7150/jca.12841. eCollection 2016.
6
Sunitinib combined with angiotensin-2 type-1 receptor antagonists induces more necrosis: a murine xenograft model of renal cell carcinoma.舒尼替尼联合血管紧张素2 1型受体拮抗剂可诱导更多坏死:肾细胞癌的小鼠异种移植模型
Biomed Res Int. 2014;2014:901371. doi: 10.1155/2014/901371. Epub 2014 May 22.
7
Gene expression profiling associated with angiotensin II type 2 receptor-induced apoptosis in human prostate cancer cells.与血管紧张素II 2型受体诱导人前列腺癌细胞凋亡相关的基因表达谱分析
PLoS One. 2014 Mar 21;9(3):e92253. doi: 10.1371/journal.pone.0092253. eCollection 2014.
8
Immunohistochemical detection of angiotensin AT 1 and AT 2 receptors in prostate cancer.前列腺癌中血管紧张素AT1和AT2受体的免疫组织化学检测
Cent European J Urol. 2011;64(4):252-5. doi: 10.5173/ceju.2011.04.art14. Epub 2011 Dec 9.
9
The Expression of MTUS1/ATIP and Its Major Isoforms, ATIP1 and ATIP3, in Human Prostate Cancer.MTUS1/ATIP 及其主要异构体 ATIP1 和 ATIP3 在人前列腺癌中的表达。
Cancers (Basel). 2011 Oct 11;3(4):3824-37. doi: 10.3390/cancers3043824.
10
Tumor and microenvironment modification during progression of murine orthotopic bladder cancer.小鼠原位膀胱癌进展过程中的肿瘤与微环境改变
Clin Dev Immunol. 2011;2011:865684. doi: 10.1155/2011/865684. Epub 2011 Oct 13.